Current and emerging treatments for cardiac amyloidosis

About this episode

The episode discusses current and future therapies for ATTR amyloidosis affecting the heart.

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Marianna Fontana from Royal Free Hospital in London, UK. They discuss the current and future state of therapies for ATTR amyloidosis affecting the heart. If you enjoy the show, please leave us a supportive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: https://heart.bmj.com/content/112/3/129

People in this episode

Host: Professor James Rudd

Guest: Professor Marianna Fontana

Topics covered

• cardiac amyloidosis
• ATTR amyloidosis
• therapies
• heart health
• medical treatments

Keywords

• cardiac amyloidosis
• ATTR amyloidosis
• treatments
• heart
• therapies
• medical research

Mentioned in this episode

Organizations: Royal Free Hospital, BMJ Group

Books & works: Heart podcast

Places: London

More episodes of Heart Podcast

• Heart failure with preserved ejection fraction plus AF - challenges and opportunities · June 2, 2026 · 31 min
• Can routine cardiac CT in patients with acute coronary syndrome and prior bypass grafts improve clinical decisions? · May 19, 2026 · 15 min
• Do older patients benefit from heart failure therapies? · May 5, 2026 · 16 min
• Simulation training in Cardiology - a missed opportunity? · April 21, 2026 · 18 min
• The natural history of aortic regurgitation · April 7, 2026 · 21 min
• Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease · March 10, 2026 · 12 min